Intech Investment Management LLC Dyne Therapeutics, Inc. Transaction History
Intech Investment Management LLC
- $10 Billion
- Q4 2024
A detailed history of Intech Investment Management LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 33,976 shares of DYN stock, worth $476,003. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,976
Previous 25,814
31.62%
Holding current value
$476,003
Previous $927,000
13.7%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
214Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$112 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$103 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$103 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$93.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$89.4 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $725M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...